Purchase Short-Term Access

Additional Factors That Could Improve Cost-Effectiveness of Pharmacogenetic-Guided Dosing in Warfarin Therapy
Mark H. Eckman, MD, MS; Jonathan Rosand, MD, MSc; Steven M. Greenberg, MD, PhD; Brian F. Gage, MD, MSc
Annals of Internal Medicine 2009;151:71. doi:10.7326/0003-4819-151-1-200907070-00017

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.